SE0303491D0 - New use VI - Google Patents

New use VI

Info

Publication number
SE0303491D0
SE0303491D0 SE0303491A SE0303491A SE0303491D0 SE 0303491 D0 SE0303491 D0 SE 0303491D0 SE 0303491 A SE0303491 A SE 0303491A SE 0303491 A SE0303491 A SE 0303491A SE 0303491 D0 SE0303491 D0 SE 0303491D0
Authority
SE
Sweden
Prior art keywords
new use
compound
formula
treatment
regurgitation
Prior art date
Application number
SE0303491A
Other languages
English (en)
Inventor
Anders Lehmann
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0303491A priority Critical patent/SE0303491D0/sv
Publication of SE0303491D0 publication Critical patent/SE0303491D0/sv
Priority to PCT/SE2004/001876 priority patent/WO2005058326A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0303491A 2003-12-19 2003-12-19 New use VI SE0303491D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0303491A SE0303491D0 (sv) 2003-12-19 2003-12-19 New use VI
PCT/SE2004/001876 WO2005058326A1 (en) 2003-12-19 2004-12-15 USE OF QUINAZOLINONE DERIVATIVES FOR THE INHIBITION OF TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS (TLESRs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303491A SE0303491D0 (sv) 2003-12-19 2003-12-19 New use VI

Publications (1)

Publication Number Publication Date
SE0303491D0 true SE0303491D0 (sv) 2003-12-19

Family

ID=30768810

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303491A SE0303491D0 (sv) 2003-12-19 2003-12-19 New use VI

Country Status (2)

Country Link
SE (1) SE0303491D0 (sv)
WO (1) WO2005058326A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306839A (en) 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
GB0413618D0 (en) * 2004-06-17 2004-07-21 Novartis Ag Organic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827988D0 (en) * 1988-11-30 1989-01-05 Smith Kline French Lab Chemical compounds
HUP0500880A2 (en) * 2000-12-11 2006-05-29 Tularik Inc Cxcr3 antagonists and pharmaceutical compositions thereof
TW200306839A (en) * 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
WO2004041755A2 (en) * 2002-11-04 2004-05-21 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics

Also Published As

Publication number Publication date
WO2005058326A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
WO2005077373A3 (en) Treatment of gastro-esophageal reflux disease (gerd)
WO2005077368A3 (en) Treatment of gastro-esophageal reflux disease (gerd)
IS7654A (is) Notkun MGLUR5 mótlyfja til meðhöndlunar á maga-vélindis-bakflæðissjúkdómum
EA200601358A1 (ru) Новые ингибиторы химазы
EA200870117A1 (ru) Азаиндоловые ингибиторы аурора-киназ
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
EA200601295A1 (ru) Производные 1,3-диоксана и их аналоги, применимые для лечения i.a. ожирения и диабета
DE60335359D1 (de) Phthalazinonderivate
CY1111481T1 (el) Υποκατεστημενα αρυλοκυκλοπροπυλακεταμιδια ως ενεργοποιητες γλυκοκινασης
EA201000050A1 (ru) Замещенные бициклолактамные соединения
NO20080942L (no) Amino-5-[4-(difluormetoksy)-fenyl]-5-fenylimidazolonforbindelser som inhibitorer av beta-sekretase (BACE)
NO20082346L (no) Hydrazonderivater og anvendelser derav
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
EA200700997A1 (ru) 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ
EA200801596A1 (ru) Новые 11-бета-гидроксиандроста-4-ен-3-оны
DE602005008471D1 (de) Aryloxyethylaminderivate mit einer kombination ausonin-wiederaufnahmehemmung
EA200600330A1 (ru) Замещённые имидазопиримидины для предупреждения и лечения рака
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
SE0401653D0 (sv) New compounds
EA200801123A1 (ru) Производные 6-гетероарилпиридоиндолона, способ их получения и применение их в терапии
EA200700555A1 (ru) Производные индола в качестве ингибиторов растворимой аденилатциклазы
SE0303491D0 (sv) New use VI
DK1562604T3 (da) Prostaglandinforbindelser til behandling af fedme
BRPI0416678A (pt) pirazolpirimidinas
SE0303490D0 (sv) New use V